OpenGate Capital Fully Exits Investment in EverZinc
1.6.2022 22:00:00 EEST | Business Wire | Press release
OpenGate Capital, a global private equity firm, announced that it has exited its investment in EverZinc, a global provider of specialty zinc materials, through a sale to U.S. Zinc, a portfolio company of Aterian Investment Partners. Terms of the investment were not disclosed.
EverZinc is headquartered in Liège, Belgium and has industrial operations in Belgium, Canada, the Netherlands, Norway, China, and Malaysia. EverZinc specializes in four product lines: fine zinc powders, zinc oxide, zinc for batteries, and Zano®, an ultra-fine zinc oxide. EverZinc products are sold to customers around the world for use in a variety of applications, including anti-corrosion paints, tires, pharmaceutical chemicals, ceramics and glass, and sunscreens.
The business is led by CEO, Vincent Dujardin, and was acquired by OpenGate Capital in 2016 through a corporate carve-out from Umicore. During OpenGate’s ownership, EverZinc grew EBITDA by 2x, and expanded its product mix and geographic footprint, all while further strengthening its ESG attributes.
Julien Lagrèze, OpenGate Partner and Head of Europe, commented on the transaction, stating, “When we acquired EverZinc, we believed the business had tremendous potential for geographic expansion and innovation, and, under Vincent’s leadership, new products were developed and new markets penetrated, which re-positioned the company for growth and enhanced profitability. It has been a truly rewarding experience working with Vincent and his team, and we’re confident that EverZinc is in great hands as it embarks on a new phase of growth.”
EverZinc will join U.S. Zinc, a global zinc chemistry and material science business, manufacturing diversified zinc products including zinc oxide, zinc powder, and zinc metal used in end markets such as tires, chemicals, coatings, and agriculture.
Commenting on the sale, Dujardin stated, “I am incredibly proud of leading EverZinc, which is an innovative, diverse, and global business that is supported by an incredibly dedicated team of people. I am confident that the business will have much success with U.S. Zinc.”
Jefferies served as lead financial advisor and Stifel served as financial advisor to OpenGate Capital.
About OpenGate Capital
OpenGate Capital is a global private equity firm specializing in the acquisition and operation of businesses to create new value through operational improvements, innovation, and growth. Established in 2005, OpenGate Capital is headquartered in Los Angeles, California with a European office in Paris, France. OpenGate’s professionals possess the critical skills needed to acquire, transition, operate, build, and scale successful businesses. To date, OpenGate Capital has executed 40 acquisitions across North America and Europe. To learn more about OpenGate, please visit www.opengatecapital.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220601005187/en/
Contact information
OpenGate Media Contacts
Prosek Partners
Email: Pro-opengate@prosek.com
Alanna Chaffin
Co-Head, Investor Relations & Communications
Email: AChaffin@opengatecapital.com
Telephone: +1 310-432-7000
OpenGate Business Development Contact
Joshua Adams
Email: jadams@opengatecapital.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Invivoscribe ® Advances Molecular Clonality Testing Portfolio with Comprehensive LymphoTrack ® Flex Suite6.10.2026 13:15:00 EEST | Press release
Invivoscribe, a global leader in precision diagnostics and measurable residual disease (MRD) testing, today announced the launch of the complete LymphoTrack Flex suite, an integrated next-generation sequencing (NGS) solution to identify and track immunoglobulin and T-cell receptor gene rearrangements. As NGS-based immune receptor MRD analysis moves from academic laboratories into routine use in oncology research centers, the demand for standardized, high-throughput workflows is accelerating. Laboratories are seeking both greater efficiency and ultra-high sensitivity. This requires increasing DNA inputs while ensuring higher testing throughput and analytical performance. Translational programs need testing that is both reproducible and scalable across sites. LymphoTrack Flex meets these demands, bringing seven molecular targets (IGHV leader, IGH FR1, IGH FR2, IGH FR3, IGK, TRB and TRG), together in one automation-ready workflow with massively parallel multiplexing and a powerful bioinfo
Degreed Agents Enable Every Leader to Upskill Their Organization with Ease6.10.2026 13:00:00 EEST | Press release
Degreed was born with the mission to help everyone get credit for all of their learning and skills. Today, the company announces the latest phase of that journey with the release of Degreed agents, a connected system of AI agents that lets leaders and L&D teams automate personalized learning and skill building. Leaders set the direction, agents do the work, and together they form the foundation of a hybrid operating system for their workforce. Businesses today run workforce transformations as a relay. The CEO sets a mandate to get everyone AI-fluent. A talent leader then defines the end state while managers try to spot gaps on their own teams. L&D pulls reports by hand and builds what they can. Each handoff adds a delay. Now, agents can orchestrate all of that in real time. Degreed agents notice details that matter, like a promotion, a skill gap, or an engagement dip, and act on them without requiring a manager to notice, an admin to flag it, or L&D to build it. At launch, agents build
OPEX® Corporation Offers a Simplified, One-Touch Document Scanning Solution with the Introduction of Axis™6.10.2026 11:00:00 EEST | Press release
OPEX® Corporation, a global leader in Next Generation Automation providing innovative solutions for warehouse, document and mail automation, has announced the launch of Axis™, a new document scanner that brings the benefits of one-touch scanning to a simplified, single-bin configuration. Designed for document capture workflows where minimal document preparation, mixed media handling or operational simplicity are priorities, Axis bridges the gap between OPEX’s desktop scanner series and its multi-bin production scanner portfolio. “We developed Axis in direct response to market demands,” said Dann Worrell, President, Document and Mail Automation, OPEX. “Our customers want to simplify their scanning processes, reduce operating costs, and improve quality. Axis delivers on these priorities by combining our minimal-prep, One-Touch scanning technology with a single-bin design. With a lower market accessible entry point, Axis helps customers process documents more efficiently while achieving m
Rothera Goes Live on Smartstream’s Air to Automate High-Volume Derivatives Reconciliations6.10.2026 11:00:00 EEST | Press release
Smartstream, the trusted data solutions provider for leading global financial institutions and enterprises, today announced that Rothera, the U.S.-based CFTC-regulated event contract market, has gone live on Smartstream’s Air. Rothera has deployed Smartstream’s Cash and Data modules to automate high-volume derivatives reconciliations across its CFTC-regulated exchange and clearinghouse business. As transaction volumes on the exchange grew, Rothera sought to scale and automate its existing reconciliation processes to support greater operational efficiency and robust audit controls. To support this growth, Rothera selected Air’s Cash and Data modules as a new implementation. The AI-powered platform ingests, matches, and reconciles high-volume data flows with minimal manual intervention, providing a fully audited environment aligned with regulatory obligations of a CFTC-regulated venue. Following an initial go-live for two data reconciliations: Exchange-to-Clearing Instruments and Exchang
Convatec Survey Challenges Assumptions About Leakage in Ostomy Care6.10.2026 10:00:00 EEST | Press release
Convatec, a leading medical products and technologies company focused on solutions for the management of chronic conditions, today released Rethinking leakage in ostomy care, new international research highlighting a significant gap in how peristomal skin health is understood and managed in ostomy care. The findings indicate that skin health plays a critical role in preventing leakage, and supporting confidence in daily life, yet remains widely under-recognised in routine care. For many people, leakage is not only a clinical or product issue; it can shape whether they feel able to travel, exercise, socialise or take part fully in everyday life. More than half of respondents said they avoid such activities due to worry about their ostomy. The results of the survey, which included more than 1,800 people living with an ostomy and over 400 healthcare professionals, point to a significant opportunity to improve outcomes through greater focus on peristomal skin health, the specific area of s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom